Please login to the form below
tirzepatide
This page shows the latest tirzepatide news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly files US lawsuits over ‘unlawful’ sales of Mounjaro counterfeits
Lilly is the only FDA-approved company to legally sell products containing tirzepatide. ... contain tirzepatide, and doing so for a use for which Mounjaro is not approved, namely weight loss.".
Latest news
-
Eli Lilly’s Mounjaro receives NICE recommendation to treat type 2 diabetes
Eli Lilly’s Mounjaro (tirzepatide) has been recommended by the National Institute for Health and Care Excellence (NICE) as a treatment for poorly controlled type 2 diabetes in adults, alongside diet
-
Eli Lilly announces $450m investment in US manufacturing site
The announcement comes after two of Lilly’s diabetes drugs – Mounjaro (tirzepatide) and Trulicity (dulaglutide) – were in short supply in December 2022, which resulted in the US Food and Drug Administration
-
Eli Lilly shares adjusted financial guidance for 2023
In addition to the tremendous ongoing launch of Mounjaro in type 2 diabetes and expected future opportunities to treat obesity and obesity-related metabolic outcomes with tirzepatide, we plan to invest ... regulatory submission for tirzepatide in
-
Eli Lilly granted fast track designation by FDA for obesity treatment
The company plans to initiate a rolling submission of a new drug application for tirzepatide this year. ... Crucially, the overall safety and tolerability profile of tirzepatide was similar to other incretin-based therapies approved for the treatment of
-
Eli Lilly announces $2.1bn investment in new manufacturing sites
The company has delivered 17 new medicines over the course of the last eight years, including tirzepatide, which received US Food and Drug Administration (FDA) approval as Mounjaro, for the treatment
More from news
Approximately 5 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
IPG Health Medical Communications
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
